Načítá se...
Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD(2) in the kidney
BACKGROUND: Lipid-metabolizing enzymes and their metabolites affect inflammation and fibrosis, but their roles in chronic kidney disease (CKD) have not been completely understood. METHODS: To clarify their role in CKD, we measured the mRNA levels of major lipid-metabolizing enzymes in 5/6 nephrectom...
Uloženo v:
| Vydáno v: | Clin Exp Nephrol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Singapore
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8038997/ https://ncbi.nlm.nih.gov/pubmed/33595729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-021-02021-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|